Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Studies on ionic mechanisms of the effects of isoproterenol on Brugada syndrome

View through CrossRef
Objective It has been reported that Adrenergic beta stimulation attenuated ST-elevation and ventricular arrhythmia and electrical storm was suppressed by treatment with low-dose isoproterenol (Iso) in some cases of Brugada syndrome. However, there have been few systematic studies on ionic mechanisms of the effects of isoproterenol. Methods Single epicardial myocytes of right ventricle of the rabbits were isolated with enzymatic dissociation. The whole-cell patch clamp recording technique was used to observe the effect of 1μM Iso on action potential duration APD), type calcium current (Ica, L) and transient outward potassium current (Ito) in epicardial myocytes of right ventricle of the rabbits. Results (1) Iso significantly prolonged APD20, D50 and APD90 from (151.3±11.8)ms, 68.7±27.3) ms and (380.9±34.6) ms to (195.4±13.3) ms, (324.5±32.8) ms and (423.5±42.1) ms (n=14, p<0.05), respectively. (2) At +60 mV, Ito decreased from (11.4±1.7) pA/pF to (6.3±0.5) pA/pF (n=16, p<0.05) after 1 μM Iso. 1 μM Iso downshifted the I-V curves of Ito without changes of their active, peak and reverse potentials; 1 μM Iso turned the steady-state inactivation curve to left and the curve of time recovery from inactivation of Ito moved right. V1/2,act and kact of Ito had no significant difference before and after 1 μM Iso. (3) 1 μM Iso increased peak ICa, L from (−6.1±0.6) pA/pF to (−8.6±0.9) pA/pF (n=10, p<0.05), respectively. 1 μM Iso downshifted the I-V curves of ICa without changes of their active, peak and reverse potentials. Conclusions Iso could prolong APD, especially APD20 and APD50; Iso blocked Ito in a voltage dependent manner and probably inhibited Ito in its inactive state; Iso augmented ICa, L in a voltage dependent manner, which could be an important mechanism to suppress ventricular arrhythmia and electrical storm of Brugada syndrome.
Title: Studies on ionic mechanisms of the effects of isoproterenol on Brugada syndrome
Description:
Objective It has been reported that Adrenergic beta stimulation attenuated ST-elevation and ventricular arrhythmia and electrical storm was suppressed by treatment with low-dose isoproterenol (Iso) in some cases of Brugada syndrome.
However, there have been few systematic studies on ionic mechanisms of the effects of isoproterenol.
Methods Single epicardial myocytes of right ventricle of the rabbits were isolated with enzymatic dissociation.
The whole-cell patch clamp recording technique was used to observe the effect of 1μM Iso on action potential duration APD), type calcium current (Ica, L) and transient outward potassium current (Ito) in epicardial myocytes of right ventricle of the rabbits.
Results (1) Iso significantly prolonged APD20, D50 and APD90 from (151.
3±11.
8)ms, 68.
7±27.
3) ms and (380.
9±34.
6) ms to (195.
4±13.
3) ms, (324.
5±32.
8) ms and (423.
5±42.
1) ms (n=14, p<0.
05), respectively.
(2) At +60 mV, Ito decreased from (11.
4±1.
7) pA/pF to (6.
3±0.
5) pA/pF (n=16, p<0.
05) after 1 μM Iso.
1 μM Iso downshifted the I-V curves of Ito without changes of their active, peak and reverse potentials; 1 μM Iso turned the steady-state inactivation curve to left and the curve of time recovery from inactivation of Ito moved right.
V1/2,act and kact of Ito had no significant difference before and after 1 μM Iso.
(3) 1 μM Iso increased peak ICa, L from (−6.
1±0.
6) pA/pF to (−8.
6±0.
9) pA/pF (n=10, p<0.
05), respectively.
1 μM Iso downshifted the I-V curves of ICa without changes of their active, peak and reverse potentials.
Conclusions Iso could prolong APD, especially APD20 and APD50; Iso blocked Ito in a voltage dependent manner and probably inhibited Ito in its inactive state; Iso augmented ICa, L in a voltage dependent manner, which could be an important mechanism to suppress ventricular arrhythmia and electrical storm of Brugada syndrome.

Related Results

Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
Brugada syndrome is a rare inherited arrhythmogenic disease leading to ventricular fibrillation and high risk of sudden death. In 1998, this syndrome was linked with a genetic vari...
Abstract 4138514: From Treatment to Trigger: A Case of Atomoxetine-Induced Brugada Pattern
Abstract 4138514: From Treatment to Trigger: A Case of Atomoxetine-Induced Brugada Pattern
Introduction: Brugada syndrome is an inherited cardiac disorder characterized by specific ECG patterns, notably the coved-type ST-segment elevation in the right precord...
Prognostic Value of Electrophysiologic Investigations in Brugada Syndrome
Prognostic Value of Electrophysiologic Investigations in Brugada Syndrome
Brugada Syndrome. Introduction: The prognostic value of electrophysiologic investigations in individuals with Brugada syndrome is unclear. Previous studies failed to dete...
Electrocardiographic Effects of Propofol versus Etomidate in Patients with Brugada Syndrome
Electrocardiographic Effects of Propofol versus Etomidate in Patients with Brugada Syndrome
Abstract Background Brugada Syndrome is an inherited arrhythmogenic disease, characterized by the typical coved type ST-segment elevation in the ...
Genetic and Molecular Mechanisms in Brugada Syndrome
Genetic and Molecular Mechanisms in Brugada Syndrome
Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardia...
CARDIOPROTECTIVE POTENTIAL OF CONVOLVULUS ARVENSIS AGAINST ISOPROTERENOL-INDUCED CARDIOTOXICITY
CARDIOPROTECTIVE POTENTIAL OF CONVOLVULUS ARVENSIS AGAINST ISOPROTERENOL-INDUCED CARDIOTOXICITY
BACKGROUND: Myocardial infarction is largely driven by oxidative stress-mediated cellular and mitochondrial dysfunction. Isoproterenol-based experimental models closely mimic these...
Brugada Syndrome and Pregnancy: Highlights on Antenatal and Prenatal Management
Brugada Syndrome and Pregnancy: Highlights on Antenatal and Prenatal Management
Introduction. Brugada syndrome is characterized by a disruption of heart’s normal rhythm. It is an autosomal dominant disease due to a mutation of SNC5A gene. Its prevalence is low...
Brugada Syndrome
Brugada Syndrome
AbstractBrugada syndrome (BrS) is characterised by right bundle branch block and persistent ST‐segment elevation in right precordial leads. It is responsible for 4–12% of total sud...

Back to Top